annual EBITDA:
-$46.10M+$59.02M(+56.15%)Summary
- As of today (May 29, 2025), AAPG annual EBITDA is -$46.10 million, with the most recent change of +$59.02 million (+56.15%) on December 1, 2024.
- During the last 3 years, AAPG annual EBITDA has risen by +$75.82 million (+62.19%).
- AAPG annual EBITDA is now -526.09% below its all-time high of -$7.36 million, reached on December 1, 2017.
Performance
AAPG EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
EBITDA Formula
EBITDA = Net Income + Interest + Taxes + Depreciation + Amortization
AAPG EBITDA Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +56.1% | - | - |
| 3 y3 years | +62.2% | - | - |
| 5 y5 years | +78.1% | - | - |
AAPG EBITDA Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | at high | +62.2% | ||||
| 5 y | 5-year | at high | +78.1% | ||||
| alltime | all time | -526.1% | +78.1% |
AAPG EBITDA History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Dec 2024 | -$46.10M(-56.1%) | - | - |
| Dec 2023 | -$105.12M(-8.5%) | - | - |
| Dec 2022 | -$114.85M(-5.8%) | - | - |
| Dec 2021 | -$121.92M(+31.1%) | - | - |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Dec 2020 | -$93.00M(-55.7%) | - | - |
| Dec 2019 | -$210.15M(+376.5%) | - | - |
| Dec 2018 | -$44.10M(+498.9%) | - | - |
| Dec 2017 | -$7.36M(-52.4%) | - | - |
| Dec 2016 | -$15.48M | - | - |
FAQ
- What is Ascentage Pharma Group International annual EBITDA?
- What is the all time high annual EBITDA for Ascentage Pharma Group International?
- What is Ascentage Pharma Group International annual EBITDA year-on-year change?
What is Ascentage Pharma Group International annual EBITDA?
The current annual EBITDA of AAPG is -$46.10M
What is the all time high annual EBITDA for Ascentage Pharma Group International?
Ascentage Pharma Group International all-time high annual EBITDA is -$7.36M
What is Ascentage Pharma Group International annual EBITDA year-on-year change?
Over the past year, AAPG annual EBITDA has changed by +$59.02M (+56.15%)